ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1717

Do Bone Marrow Edema (BME) Lesions In The Sacroiliac Joint (SIJ) Change Into Fatty Lesions Over a 3-Month Period In Patients With Axial Spondyloarthritis (axSpA)?

Manouk de Hooge1, Rosaline van den Berg2, Victoria Navarro-Compán2, Monique Reijnierse3, Floris van Gaalen2, Karen Fagerli4, Robert Landewé5, Maikel van Oosterhout6, Roberta Ramonda7, Tom Huizinga2 and Désiréé van der Heijde1, 1Leiden University Medical Center, Leiden, Netherlands, 2Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 3Radiology, Leiden University Medical Center, Leiden, Netherlands, 4Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 5Int Med/Rheumatology, Academic Medical Center, Amsterdam, Netherlands, 6Rheumatology, GHZ Hospital, Gouda, Netherlands, 7Rheumatology Unit, University of Padova, Padova, Italy

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: MRI and spondylarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Imaging in Pediatric Arthritis, Spondyloarthritis and Osteoarthritis

Session Type: Abstract Submissions (ACR)

Background/Purpose: BME lesions may change into fatty lesions in the SIJ over time. In one study significant changes of fatty lesions in the SI joints were observed over 1 year in patients with axSpA1. It is unknown if similar results are found with a shorter follow-up period. Therefore we investigate whether BME lesions in the SIJ seen on MRI change into fatty lesions over a 3-month period in patients with axSpA.

Methods: Patients with back pain (≥3 months, ≤2 years, onset <45 years) from the 5 participating centres of the SPondyloArthritis Caught Early (SPACE)-cohort were included. All patients fulfilling the ASAS axSpA criteria underwent MRI-SI at baseline (MRI-SI-baseline) and after 3 months (MRI-SI-3months). MRI-SI-baseline and MRI-SI-3months were scored by 2 well-calibrated readers independently, blinded for time point, for the presence of BME and fatty lesions on STIR and MRI T1-weighted images viewed simultaneously. BME and fatty lesions were defined present if 1 lesion was seen on ≥2 consecutive slices or if >1 lesion were seen on a single slice. The scores of baseline and 3 months were compared on quadrant level (Q) and the sum of all quadrants (8 total) was calculated to obtain patient scores. Scores of the readers are reported separately.  

Results: Only axSpA patients with MRI-SI-baseline and MRI-SI-3months were included for this analysis (n=83, number of Q=664). In 62/83 patients (74.7%) reader 1 indicated the presence of BME or fatty lesions at any time point, reader 2 indicated this in 60/83 patients (72.3%). Readers agreed in 73/83 patients (88%) on the presence of lesions at any time point. Reader 1 indicated no lesions at baseline or follow-up in 410/664 Qs (61.7%) and in 131/664 Qs (19.7%) the type of lesions did not change over time. In 123/664 Qs (18.5%) lesions occurred, disappeared or changed from one type to another. In total, there were 34/664 Qs (5.1%) in which fatty lesions occurred, and 29/664 Qs (4.4%) in which fatty lesions disappeared. In only 3/664 Qs (0.5%) BME lesions on MRI-SI-baseline turned into FAT lesions on MRI-SI-3months. In the same amount of Qs the opposite thing is happening; FAT lesions change into BME lesions over time. The results of both readers show similar trends (see table).

Conclusion: We find a lot of volatility of BME and fatty lesions over 3 months time. It is common for both lesions to occur without a previous lesion or disappear completely without leaving a mark, but it is uncommon to see BME lesions turn into fatty lesions over a period of 3 months. This observation casts serious doubts on the value of fatty lesions as a surrogate for previous inflammation.

Reference: 1Song ARD 2011;70:1257-63

Reader 1

3 months

no lesions

BME

FAT

BME & FAT

Baseline

 

 

no lesions

410

17

22

1

BME

28

58

3

8

FAT

15

3

52

11

BME & FAT

7

4

4

21

Reader 2

3 months

no lesions

BME

FAT

BME & FAT

Baseline

 

 

no lesions

395

19

11

0

BME

32

79

4

6

FAT

4

5

56

9

BME & FAT

3

2

14

25


Disclosure:

M. de Hooge,
None;

R. van den Berg,
None;

V. Navarro-Compán,
None;

M. Reijnierse,
None;

F. van Gaalen,
None;

K. Fagerli,
None;

R. Landewé,
None;

M. van Oosterhout,
None;

R. Ramonda,
None;

T. Huizinga,
None;

D. van der Heijde,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/do-bone-marrow-edema-bme-lesions-in-the-sacroiliac-joint-sij-change-into-fatty-lesions-over-a-3-month-period-in-patients-with-axial-spondyloarthritis-axspa/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology